FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C502 MODULE

MDR report key: 4170042 · Received October 14, 2014

Report

Report Number
1823260-2014-07858
Event Type
Malfunction
Date Received
October 14, 2014
Date of Event
September 4, 2014
Report Date
January 5, 2015
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. ADDITIONAL INFORMATION FOR FURTHER INVESTIGATION WAS REQUESTED BUT WAS NOT PROVIDED.

Description of Event or Problem · 1

THE CUSTOMER ALLEGED THEY RECEIVED QUESTIONABLE TINA-QUANT ALBUMIN GEN.2 (ALB), TOTAL PROTEIN URINE/CSF GEN.3 (UPRO), AND CREATININE FOR ONE PATIENT. THE CUSTOMER PROVIDED DATA FOR DISCREPANT ALB AND UPRO RESULTS ON THEIR C502 ANALYZER. THE PATIENT'S RESULTS WERE FROM A URINE SAMPLE. THE UNITS OF MEASURE WERE REQUESTED BUT NOT PROVIDED. THE PATIENT'S INITIAL ALB RESULT WAS 2.5 AND UPRO RESULT WAS 0.61. THE RESULTS WERE AUTO-ACCEPTED AND REPORTED TO THE CUSTOMER'S LABORATORY INFORMATION SYSTEM. THE PATIENT'S SAMPLE WAS THEN TESTED ON ANOTHER C502 ANALYZER. THE PATIENT'S ALB RESULT WAS 654.7 ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS REPEATED WITH DECREASED VOLUME AND THE RESULT WAS 930. THE PATIENT'S UPRO RESULT WAS 1.84. THE SAMPLE WAS REPEATED AGAIN ON THE OTHER C502 ANALYZER. THE PATIENT'S ALB RESULT WAS 687.9 ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS REPEATED WITH DECREASED VOLUME AND THE RESULT WAS 908.6. THE PATIENT'S UPRO RESULT WAS 1.85. THERE WERE NO ADVERSE EVENTS. THE ALB REAGENT LOT NUMBER WAS 699769 AND THE UPRO REAGENT LOT NUMBER WAS 697110. THE EXPIRATION DATES WERE REQUESTED BUT NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
651945 COBAS 8000 C502 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1